| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 12/30/2004 | US20040266801 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd) |
| 12/30/2004 | US20040266797 Use of potent,selective and non toxic c-kit inhibitors for treating tumor angiogensis |
| 12/30/2004 | US20040266779 Use of c-kit inhibitors for the treatment of myeloma |
| 12/30/2004 | US20040266771 Use of tyrosine kinase inhibitors for treating bone loss |
| 12/30/2004 | US20040266746 the sensitivity of cells typical of various proliferative disorders to the ansamycin CNF-101 ("17-AAG") is proportional to the HER-2 levels in those cells |
| 12/30/2004 | US20040266742 Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease |
| 12/30/2004 | US20040266736 Particularly preferred inhibitors are low molecular weight substances unable to cross the blood/brain barrier, and act systemically and not centrally |
| 12/30/2004 | US20040266723 Antiviral agents for treatment of Flaviviridae infections |
| 12/30/2004 | US20040266722 4'-Substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| 12/30/2004 | US20040266710 Immunotherapy; induce immunology response |
| 12/30/2004 | US20040266709 Immunotherapy; induction immunology response |
| 12/30/2004 | US20040266702 Topical treatment or prevention of ocular infections |
| 12/30/2004 | US20040266701 Novel polyol macrolide antitumor-antibiotics from the novel actinomycete strain CNQ140 |
| 12/30/2004 | US20040266698 Pyrane derivatives as both ace-and nep-inhibitors |
| 12/30/2004 | US20040266692 Gastrointestinal disorders |
| 12/30/2004 | US20040266686 Administering endothelial growth factor antagonist; wound healing agents |
| 12/30/2004 | US20040266682 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits |
| 12/30/2004 | US20040266679 Isolated ucleic acid; nucleotide sequence coding protein; detection moderators of kinase peptide |
| 12/30/2004 | US20040266678 Methods and compositions for treating polycystic ovary syndrome |
| 12/30/2004 | US20040266676 Preventives/remedies for proliferative organ diseases chronic arthritic diseases. hypertrophic scar or keloid |
| 12/30/2004 | US20040266675 Transgenic aniomal nmodels; screening; administering peptide |
| 12/30/2004 | US20040266670 Reduce blood glucose concentration |
| 12/30/2004 | US20040266661 Method for reducing hypertension and heart failure |
| 12/30/2004 | US20040266660 Hdl for the treatment of stroke and other ischemic conditions |
| 12/30/2004 | US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells |
| 12/30/2004 | US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening |
| 12/30/2004 | US20040265841 Analyzing mutations in Myosin Light Chain 2a; titin-related diseases; drug screening; animal models; knockout cells; transgenic zebrafish; antibodies |
| 12/30/2004 | US20040265837 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 12/30/2004 | US20040265819 Uricosuric regulating action using protein comprising an amino acid sequence represented by SEQ ID NO:1 or an amino acid sequence derived therefrom being capable of transporting uric acid and its analogs; cardiovascular disorders; gout; hypotensive agents; nucleotide sequences; antibodies; modulators |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265804 Method for identifying metastatic tumor cells |
| 12/30/2004 | US20040265791 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 12/30/2004 | US20040265462 Nutritional supplement |
| 12/30/2004 | US20040265398 administering dietetics comprising plant extracts and optionally stimulants and/or glucosamine as anorexigenic agents |
| 12/30/2004 | US20040265396 comprises zinc oxide, calcium channel blocker (3,5-pyridinedicarboxylic acid or nifedipine), and fat-soluble vitamins (vitamins A, D, E, K) admixed with antibacterial and antifungal agents; administered orally or topically |
| 12/30/2004 | US20040265393 Non-invasive intravascular thrombolysis using modified ultrasound techniques |
| 12/30/2004 | US20040265388 Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 12/30/2004 | US20040265370 Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
| 12/30/2004 | US20040265364 Transdermal mixture for pain relief includes amitriptyline, clonidine, ketamine and antiinflammatory agent in pentravan gel; may contain local anesthetic lidocaine or EMLA; analgesics |
| 12/30/2004 | US20040265362 Adhesive, skin and/or nail permeation enhancer; drug contained in contact layer; and binders, crosslinking agents, softeners, solvents, fillers and/or antioxidants; occlusive backing; fungal infection treatment of onychomycosis |
| 12/30/2004 | US20040265350 Ceramic carrier comprising interconnected skeleton of scaffolding and struts having pores; low density; time-release agents; fibroblast-, or transforming growth factors; bone morphogenic proteins, somatotrophin; antibiotics, vitamins, proteins, hormones, radiopacity agents |
| 12/30/2004 | US20040265320 Administering a compound selected from 3-O-(3',3'-dimethylsuccinyl) betulinic acid, 3-O-(3',3'-dimethylsuccinyl) betulin, 3-O-(3',3'-dimethylglutaryl) betulin, 3-O-(3',3'-dimethylsuccinyl) dihydrobetulinic acid, 3-O-(3',3'-dimethylglutaryl) betulinic acid, (3',3'-dimethylglutaryl) dihydrobetulinic acid |
| 12/30/2004 | US20040265317 Methods and compositions useful for inhibition of angiogenesis |
| 12/30/2004 | US20040265311 Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activity |
| 12/30/2004 | US20040265291 Compositions and methods for restoring bacterial flora |
| 12/30/2004 | US20040265276 Medicinal combination useful for in vivo exogenic transfection and expression |
| 12/30/2004 | US20040265238 Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 12/30/2004 | US20040261190 Hydrazono-malonitriles |
| 12/30/2004 | DE202004017112U1 Herbal composition especially for use in diet plans for diabetes mellitus contains Momordica charantia (bitter melon) and other plant parts |
| 12/30/2004 | DE10325752A1 Lektin-Konjugate Lectin conjugates |
| 12/30/2004 | CA2469140A1 Hcv regulated proteins |
| 12/29/2004 | WO2004113523A1 Granzyme b/golgin-160 interaction inhibitor |
| 12/29/2004 | WO2004113502A2 Identification of therapeutic agents using genetic fingerprinting |
| 12/29/2004 | WO2004113375A2 Antimicrobial compositions and uses thereof |
| 12/29/2004 | WO2004113286A2 Mucin synthesis inhibitors |
| 12/29/2004 | WO2004113274A2 Diaryl ureas with kinase inhibiting activity |
| 12/29/2004 | WO2004112837A1 PREPARATION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1α PRODUCTION INHIBITOR |
| 12/29/2004 | WO2004112805A1 Antimicrobial silver comprising silver |
| 12/29/2004 | WO2004112800A1 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids |
| 12/29/2004 | WO2004112797A1 Hormone replacement- and depression therapy comprising dienogest |
| 12/29/2004 | WO2004112796A1 Treatment of amd with combination of ingredients |
| 12/29/2004 | WO2004112795A1 Ltb4 compositions for treating tract infections |
| 12/29/2004 | WO2004112788A1 Pyridoxamine for the treatment of diabetic kidney disease |
| 12/29/2004 | WO2004112773A1 Pharmaceutical compositions used for immune disease treatment and improvement |
| 12/29/2004 | WO2004112772A1 Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis |
| 12/29/2004 | WO2004112766A1 Composition for lowering blood glucose |
| 12/29/2004 | WO2004112764A1 Suppressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same |
| 12/29/2004 | WO2004112763A2 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 12/29/2004 | WO2004112756A1 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| 12/29/2004 | WO2004112751A1 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 12/29/2004 | WO2004112566A2 Diagnosis and treatment of nephropathy |
| 12/29/2004 | WO2004098713A3 Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4) |
| 12/29/2004 | WO2004084880B1 METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS |
| 12/29/2004 | WO2004078157A3 Regulation of mammalian hair growth |
| 12/29/2004 | WO2004064727A3 Method of cancer treatment using hdac inhibitors |
| 12/29/2004 | WO2004015072A3 Mrbs as modifiers of the rb pathway and methods of use |
| 12/29/2004 | WO2004007682A3 Methods and compositions for modulating t helper (th) cell development and function |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | WO2004001014A3 Osteopontin, oligodendrocytes and myelination |
| 12/29/2004 | WO2003092542A8 Injectable chondrocyte implant |
| 12/29/2004 | WO2003082370A3 Transcellular drug delivery system |
| 12/29/2004 | WO2003068983A9 Use of the axl receptor for diagnosis and treatment of renal disease |
| 12/29/2004 | WO2003057178A3 Viral capsid assembly intermediates |
| 12/29/2004 | WO2003057146A3 Novel compositions and methods for cancer |
| 12/29/2004 | WO2003045984A3 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 12/29/2004 | WO2003025200A3 Methods of using 22417, a novel human aminoprotease family member |
| 12/29/2004 | WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 12/29/2004 | WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 12/29/2004 | EP1491632A2 Anti-alphavbeta3 humanized monoclonal antibodies |
| 12/29/2004 | EP1491236A1 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 12/29/2004 | EP1491208A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 12/29/2004 | EP1491201A1 Methods of reducing toxicity of 5-fluorouracil with acylated pyrimidine nucleosides |
| 12/29/2004 | EP1491200A1 Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications |
| 12/29/2004 | EP1491198A1 use of vitamin d derivatives to enhance efficacy of cytotoxic agents |
| 12/29/2004 | EP1491187A1 Preventive or therapeutic agent for kidney disease |
| 12/29/2004 | EP1491183A2 Use of a plant extract of the Rosaceae family |
| 12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/29/2004 | EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 12/29/2004 | EP1490689A1 Novel compositions and methods in cancer associated with altered expression of prlr |